Chairman King, Vice Chairman DeSantis, Ranking Member Cohen, and members of the
Subcommittee, the Alliance of Specialty Medicine (the “Alliance”) thanks you for your
focus on the issue of attorney advertising related to pharmaceutical, biological, and
medical device products. The Alliance represents more than 100,000 specialty
physicians who are deeply committed to improving access to specialty medical care
through the advancement of sound health policy. We appreciate the opportunity to
submit written testimony for the record.
Aggressive and misleading advertisements about pharmaceuticals and medical devices
apparently have become a worthwhile investment for trial lawyers. For example,
attorney advertisement spending on one specific pharmaceutical jumped to $1.2 million
in July 2014. The number of ads related to that same pharmaceutical exceeded 1,800
by that same month.
…
Read full article here
